Edition:
India

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (0874.HK)

0874.HK on Hong Kong Stock

28.75HKD
17 Aug 2018
Change (% chg)

HK$-0.45 (-1.54%)
Prev Close
HK$29.20
Open
HK$29.90
Day's High
HK$30.30
Day's Low
HK$27.90
Volume
2,406,000
Avg. Vol
4,413,213
52-wk High
HK$42.50
52-wk Low
HK$19.00

Latest Key Developments (Source: Significant Developments)

Guangzhou Baiyunshan Pharmaceutical Holdings unit receives GMP certificate
Tuesday, 24 Jul 2018 

July 24 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS> ::* Says its wholly owned subsidiary received goods manufacture practice (GMP) certificate from Guangdong Food and Drug Administration .* Certificate issued small-volume injection manufactured by the unit and the valid period is until June 26, 2023.  Full Article

Guangzhou Baiyunshan Pharmaceutical's Unit Signs Framework Agreement On Production Expansion Project
Wednesday, 4 Jul 2018 

July 4 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS>0874.HK::SAYS UNIT SIGNS FRAMEWORK AGREEMENT ON PRODUCTION EXPANSION PROJECT WITH INVESTMENT OF ABOUT 800 MILLION YUAN ($120.65 million).  Full Article

Guangzhou Baiyunshan Pharmaceutical Updates On Acquisition
Friday, 13 Apr 2018 

April 13 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings <600332.SS>::RECEIVED LETTER OF NO FURTHER REVIEW FROM ANTI-MONOPOLY BUREAU OF MINISTRY OF COMMERCE OF PRC.PROPOSED ACQUISITION NOT SUBJECT TO FURTHER REVIEW, CO MAY PROCEED WITH ACQUISITION FROM APRIL 9.  Full Article

Guangzhou Baiyunshan Pharmaceutical Holdings unit receives GMP certificate
Monday, 5 Mar 2018 

March 5(Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS>:Says co's unit Guangzhou Baiyunshan Tianxin Pharmaceutical Co Ltd received goods manufacture practice (GMP) certificate from Guangdong Food and Drug Administration, for powder-injection, small-volume injection, tablet, hard capsule, dry suspension and granule.Says the valid period is until Feb. 22, 2023.  Full Article

Guangzhou Baiyunshan Pharmaceutical Holdings unit receives GMP certificate
Friday, 5 Jan 2018 

Jan 5 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS>:Says Guangzhou-based pharmacy unit received goods manufacture practice (GMP) certificate from Guangdong Food and Drug Administration .Certificate issued to oral dosage, Cephalospora capsule, sirup, granules and tablet manufactured by the unit and the valid period is until Dec. 19, 2022.  Full Article

Guangzhou Baiyunshan Pharmaceutical Holdings says result of arbitration
Tuesday, 26 Dec 2017 

Dec 26 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS>:Says it received arbitral awards regarding arbitration filed by the co against GOLDEN FORCE PHARMACY LIMITED, from South China International Economic and Trade Arbitration Commission .According to the result of arbitration, GOLDEN FORCE PHARMACY LIMITED will transfer 98.4 million shares(48 percent stake) of Guangzhou Wanglaoji Pharmaceutical Company Limited to the co, at the price of 3.75 yuan per share, for 368.9 million yuan in total .Says GOLDEN FORCE PHARMACY LIMITED will bear partial arbitration fees and other fees .  Full Article

Guangzhou Baiyunshan Pharmaceutical To Acquire Stake In Guangzhou Pharma
Friday, 22 Dec 2017 

Dec 22 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS>0874.HK::SAYS IT PLANS TO ACQUIRE 30 PERCENT STAKE IN GUANGZHOU PHARMA FOR 1.09 BILLION YUAN ($165.84 million).SAYS TO OWN 80 PERCENT STAKE OF GUANGZHOU PHARMA AFTER THE TRANSACTION.SAYS SELLER HAS THE OPTION TO SELL THE REMAINING 20 PERCENT STAKE IN GUANGZHOU PHARMA.  Full Article

Guangzhou Baiyunshan Pharmaceutical Updates On Suspension Of Trading Of A Shares
Monday, 4 Dec 2017 

Dec 4 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS>::REFERS TO ANNOUNCEMENT OF COMPANY DATED 30 OCTOBER IN RELATION TO SUSPENSION OF TRADING OF A SHARES.‍AS AT 4 DEC, PROPOSED ACQUISITION IS IN PROGRESS​.GIVEN UNCERTAINTY REGARDING PROPOSED PURCHASE, CO'S A SHARES TO CONTINUE TO BE SUSPENDED.  Full Article

Guangzhou Baiyunshan Pharmaceutical Updates On Suspension Of A Shares
Wednesday, 29 Nov 2017 

Nov 29 (Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS>::‍CO EXPECTS THAT TRADING IN A SHARES WILL BE SUSPENDED FOR NOT MORE THAN ONE MONTH FROM 30 NOVEMBER 2017​.‍EXPECTS IT WON'T BE ABLE TO DISCLOSE PRELIMINARY SCHEME OF PROPOSED ACQUISITION BY 30 NOVEMBER 2017 AS SCHEDULED​.  Full Article

Guangzhou Baiyunshan Pharmaceutical Holdings unit signs strategic cooperation framework agreement
Tuesday, 28 Nov 2017 

Nov 28(Reuters) - Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd <600332.SS> ::Says its unit signed a biomedical industry strategic cooperation framework agreement with Shanghai-based biotechnology firm, to cooperate in biopharmaceutical industry field .  Full Article